Defining an Optimal Adherence Threshold for Patients Taking Subcutaneous Anti-TNFs for Inflammatory Bowel Diseases

Defining an Optimal Adherence Threshold for Patients Taking Subcutaneous Anti-TNFs for Inflammatory Bowel Diseases

American Journal of Gastroenterology 113,
276 (February 2018). doi:10.1038/ajg.2017.438

Authors: Shail M Govani, Mohamed Noureldin, Peter D R Higgins, Michele Heisler, Sameer D Saini, Ryan W Stidham, Jennifer F Waljee & Akbar K Waljee

Source: The American Journal of Gastroenterology - February 22, 2018 Category: Gastroenterology Authors: Shail M Govani Mohamed Noureldin Peter D R Higgins Michele Heisler Sameer D Saini Ryan W Stidham Jennifer F Waljee Akbar K Waljee Source Type: research